UBS Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,355
Closed -$24K 9969
2021
Q3
$24K Sell
1,355
-1,264,467
-100% -$22.4M ﹤0.01% 5869
2021
Q2
$12.3M Sell
1,265,822
-56,762
-4% -$551K ﹤0.01% 1377
2021
Q1
$14.2M Buy
1,322,584
+577,954
+78% +$6.21M ﹤0.01% 1239
2020
Q4
$11M Buy
744,630
+743,813
+91,042% +$10.9M ﹤0.01% 1338
2020
Q3
$12K Sell
817
-4,483
-85% -$65.8K ﹤0.01% 5856
2020
Q2
$43K Sell
5,300
-6,013
-53% -$48.8K ﹤0.01% 5164
2020
Q1
$46K Buy
+11,313
New +$46K ﹤0.01% 5020
2019
Q4
Sell
-29,208
Closed -$9K 7318
2019
Q3
$9K Buy
29,208
+14,143
+94% +$4.36K ﹤0.01% 6274
2019
Q2
$5K Sell
15,065
-1,441
-9% -$478 ﹤0.01% 6534
2019
Q1
$11K Buy
16,506
+11,040
+202% +$7.36K ﹤0.01% 5944
2018
Q4
$9K Buy
5,466
+2,957
+118% +$4.87K ﹤0.01% 6383
2018
Q3
$15K Buy
2,509
+1,706
+212% +$10.2K ﹤0.01% 6057
2018
Q2
$5K Buy
803
+322
+67% +$2.01K ﹤0.01% 6567
2018
Q1
$3K Buy
+481
New +$3K ﹤0.01% 6568
2017
Q4
Sell
-1,230
Closed -$6K 7068
2017
Q3
$6K Buy
+1,230
New +$6K ﹤0.01% 6251
2017
Q2
Sell
-1,997
Closed -$12K 6965
2017
Q1
$12K Buy
1,997
+720
+56% +$4.33K ﹤0.01% 5598
2016
Q4
$7K Buy
1,277
+1,077
+539% +$5.9K ﹤0.01% 6141
2016
Q3
$3K Buy
200
+34
+20% +$510 ﹤0.01% 6386
2016
Q2
$1K Buy
+166
New +$1K ﹤0.01% 6664
2016
Q1
Sell
-2,014
Closed -$25K 6969
2015
Q4
$25K Buy
2,014
+889
+79% +$11K ﹤0.01% 5374
2015
Q3
$15K Buy
+1,125
New +$15K ﹤0.01% 5683